taking doses early repeatedly can lead to uneven drug accumulation and unpredictable side effects
Petkova-Kirova et al., 2008a,b)
The EM structure of Tirzepatide bound to the complete GIPR and G-proteins (Figure 3, PDB ID 7rbt, Sun et al., 2022) shows some hydrophobic and some specific polar interactions between the peptidic drug and the GIP receptor molecule
These are not optional details
Conference Reports for NATAP The Liver Meeting AASLD 2024 Nov 15-19, San Diego, CA Back Phase 3 ESSENCE trial: Semaglutide in metabolic dysfunction-associated steatohepatitis P.N
Board-certified physicians review submitted information to identify absolute contraindications including personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, pregnancy or breastfeeding, and documented serious allergic reactions to GLP-1 medications